Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the...

  • Thursday, October 4, 2012, 3:41 PM ET
    A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the company lowered its Q3 revenue outlook late yesterday. Barclay's downgrades the shares to Equalweight, JMP to Market Perform, First Analysis to Equal Weight, Summer Street to Neutral, BMO and RBC to Underperform, and Well Fargo to Market Perform. Wells also also hacked it's price target range on the shares to $15 - $16 from $29 - $31.
Track new comments on this story

This news story has 1 comment:

  •  
    The influence that orthopedic reps have is amazing as we just saw see here. The sales reps have tight relationships with orthopedic surgeons to the point that they are unethical and will probable be illegal as the sunshine act gets enforced. Worse is the distribution companies that orthopedic surgeons have formed to make even more money over and above their usual medical practice and surgery centers.
    5 Oct 2012, 01:39 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »